Dow Up 0.12% Nasdaq Up 1.35%

Galena Biopharma, Inc. (GALE)

-NasdaqCM
1.83 Down 0.03(1.61%) Oct 20, 4:00PM EDT
Prev Close:1.86
Open:1.86
Bid:1.84 x 11000
Ask:N/A
1y Target Est:5.91
Beta:0.84
Next Earnings Date: 6-Nov-14GALE Earnings announcement
Day's Range:1.75 - 1.89
52wk Range:1.56 - 7.77
Volume:980,884
Avg Vol (3m):1,910,640
Market Cap:216.32M
P/E (ttm):N/A
EPS (ttm):-0.75
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALE

Comparison

Symbol% ChgMkt Cap
GALEDown 1.61%216.32M
CELGUp 4.40%73.55B
VSTMUp 2.79%237.75M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):31.45
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.42
Quarterly EPS Est (Sep-14) :-0.11
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology treatments that address major unmet medical needs to advance cancer care. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback